Ethic Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.31M Buy
75,093
+3,821
+5% +$423K 0.15% 146
2025
Q1
$7.93M Sell
71,272
-33,372
-32% -$3.71M 0.16% 134
2024
Q4
$9.67M Buy
104,644
+7,638
+8% +$706K 0.2% 100
2024
Q3
$7.11M Buy
97,006
+7,482
+8% +$548K 0.18% 120
2024
Q2
$6.14M Sell
89,524
-7,482
-8% -$513K 0.14% 149
2024
Q1
$7.11M Sell
97,006
-15,772
-14% -$1.16M 0.18% 120
2023
Q4
$9.14M Buy
112,778
+4,423
+4% +$358K 0.27% 74
2023
Q3
$8.12M Buy
108,355
+7,508
+7% +$563K 0.28% 72
2023
Q2
$7.77M Buy
100,847
+5,808
+6% +$448K 0.29% 71
2023
Q1
$7.89M Buy
95,039
+31,117
+49% +$2.58M 0.32% 62
2022
Q4
$5.49M Buy
63,922
+19,028
+42% +$1.63M 0.3% 77
2022
Q3
$2.77M Buy
44,894
+13,979
+45% +$862K 0.19% 133
2022
Q2
$1.91M Buy
30,915
+3,895
+14% +$241K 0.13% 200
2022
Q1
$1.61M Sell
27,020
-3,626
-12% -$216K 0.11% 240
2021
Q4
$2.23M Sell
30,646
-12,477
-29% -$906K 0.17% 145
2021
Q3
$3.01M Sell
43,123
-6,690
-13% -$467K 0.31% 75
2021
Q2
$3.43M Buy
49,813
+15,969
+47% +$1.1M 0.42% 48
2021
Q1
$2.19M Buy
33,844
+14,567
+76% +$941K 0.39% 53
2020
Q4
$1.12M Buy
19,277
+4,419
+30% +$257K 0.3% 82
2020
Q3
$939K Buy
14,858
+3,772
+34% +$238K 0.36% 63
2020
Q2
$853K Buy
11,086
+1,446
+15% +$111K 0.49% 46
2020
Q1
$721K Buy
9,640
+1,878
+24% +$140K 0.6% 46
2019
Q4
$504K Buy
+7,762
New +$504K 0.37% 89